Definium Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Definium Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $859.00K, a 973.75% increase year-over-year.
- Definium Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $1.20M, a 404.64% increase year-over-year.
- Definium Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $98.00K, a 206.25% increase year-over-year.
- Definium Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $80.00K, a 26.61% decline year-over-year.
- Definium Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $49.00K, a 76.21% decline from fiscal 2022.
- Definium Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $206.00K, a 96.40% decline from fiscal 2021.
- Definium Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $5.72M, a 783.02% increase from fiscal 2020.
- Definium Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $648.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $859.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.20M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $98.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $80.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $237.00K 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $32.00K 10-Q · filed 2025-11-06 | $671.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $109.00K 10-Q · filed 2025-11-06 | $688.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-03-31 | $530.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $49.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $49.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $206.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $42.00K 10-Q · filed 2023-11-02 | $340.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $41.00K 10-Q · filed 2023-08-03 | $613.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $123.00K 10-Q · filed 2023-05-04 | $4.67M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $5.72M 10-K · filed 2023-03-09 |
| 2021-09-30 | $315.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $4.10M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $1.18M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $648.00K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |